Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by GlobeNewswire
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
99
100
Next >
AtmosZero Opens New Factory in Colorado to Deliver Decarbonized Steam Globally
February 10, 2025
From
AtmosZero, Inc.
Via
GlobeNewswire
Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
February 10, 2025
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Wärtsilä introduces next-generation engine to balance renewables and improve power plant performance
February 10, 2025
From
Wartsila
Via
GlobeNewswire
Crisil Coalition Greenwich Names Mizuho Best Bank for Corporate Banking in the U.S.
February 10, 2025
From
Mizuho Americas
Via
GlobeNewswire
Tickers
MFG
Music Licensing, Inc. Receives Official Federal Recognition of Its Wholly Owned Subsidiary, Pro Music Rights, as a Performing Rights Organization in the United States Federal Register
February 10, 2025
From
Music Licensing, Inc.
Via
GlobeNewswire
Tickers
SONG
SONGD
Recludix Pharma to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 10, 2025
From
Recludix Pharma, Inc.
Via
GlobeNewswire
GCM Grosvenor Reports Fourth Quarter and Full Year 2024 Earnings Results, with 2024 Fundraising Increasing 41%, and Year-to-Date GAAP Net Income, Fee-Related Earnings and Adjusted Net Income Increasing 46%, 19% and 36%, Respectively, Year-Over-Year
February 10, 2025
From
GCM Grosvenor
Via
GlobeNewswire
Tickers
GCMG
Palvella Therapeutics to Expand Phase 3 SELVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations to Include the Younger Pediatric Population, Children 3 to 5 Years Old
February 10, 2025
From
Palvella Therapeutics Inc.
Via
GlobeNewswire
Tickers
PVLA
Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis
February 10, 2025
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma
February 10, 2025
From
Tempest Therapeutics
Via
GlobeNewswire
Tickers
TPST
SimiTree Promotes Natalie Alexander to Director of Cost Reporting
February 10, 2025
From
SimiTree
Via
GlobeNewswire
PureSky Energy Welcomes Rami Khadra as Chief Financial Officer
February 10, 2025
From
PureSky US Services LLC
Via
GlobeNewswire
Lenders Maintain Optimism After a Banner Year for Leveraged Credit
February 10, 2025
From
FTI Consulting, Inc.
Via
GlobeNewswire
Tickers
FCN
Quantum Biopharma Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs
February 10, 2025
From
Quantum BioPharma
Via
GlobeNewswire
Tickers
CSE:QNTM
QNTM
Stardust Power Announces Exclusive Licensing Agreement for Lithium Brine Concentration Technology from KMX Technologies
February 10, 2025
From
Stardust Power Inc.
Via
GlobeNewswire
Tickers
SDST
SDSTW
Alterity Therapeutics Raises A$40.0 million in Placement
February 10, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Tickers
ASX
ATHE
Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on February 25
February 10, 2025
From
Can-Fite BioPharma Ltd.
Via
GlobeNewswire
Goliath Drills Intrusive Feeder Assaying 12.03 g/t AuEq Over 10.00 Meters Including 19.91 g/t AuEq Over 6.00 Meters And Discovers Five New Stacked Gold Veins That Remain Open Confirming An Extensive Gold Rich Source At Depth On Surebet, Golden Triangle,
February 10, 2025
From
Goliath Resources Limited
Via
GlobeNewswire
Tickers
GOTRF
TSX-V:GOT
Orion Group Holdings Awarded $211.7 Million in New Contracts
February 10, 2025
From
Orion Group Holdings, Inc.
Via
GlobeNewswire
Tickers
ORN
With No Competing Offers, Beacon Roofing’s Board Stalls and Misleads
February 10, 2025
From
QXO, Inc.
Via
GlobeNewswire
Tickers
QXO
INmune Bio Announces Plan to Submit FDA Biologics License Application (BLA) Seeking Approval of CORDStrom for Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
February 10, 2025
From
INmune Bio, Inc.
Via
GlobeNewswire
Tickers
INMB
Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer
February 10, 2025
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Tickers
IOVA
Beamr CEO will Present a Keynote Speech at the ACM Mile-High-Video 2025
February 10, 2025
From
Beamr Imaging Ltd.
Via
GlobeNewswire
Tickers
BMR
Cyber Acoustics New Professional Wireless Headset Makes the Most Advanced Noise Cancelation Technology Accessible to Everyone
February 10, 2025
From
Cyber Acoustics, Inc.
Via
GlobeNewswire
Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update
February 10, 2025
From
Roivant Sciences
Via
GlobeNewswire
Tickers
ROIV
ECARX AutoGPT Integrates DeepSeek-R1 Model
February 10, 2025
From
ECARX LIMITED
Via
GlobeNewswire
Tickers
ECX
Atlantic International Corp. Enters Up to $10 Million Workforce Agreement with Leading Industrial Distributor
February 10, 2025
From
Atlantic International Corp.
Via
GlobeNewswire
Tickers
ATLN
Amicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025
February 10, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Axsome Therapeutics Announces Settlement Agreement Resolving AUVELITY® (dextromethorphan HBr – bupropion HCl) Patent Litigation
February 10, 2025
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
BCI Completes Sale of Majority Stake in Hayfin
February 10, 2025
From
BCI - British Columbia Investment Management Corp
Via
GlobeNewswire
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.